Minimally invasive aortic valve replacement: late conversion to full sternotomy doubles operative time

Signe Foghsgaard1, Thomas Andersen Schmidt, Henrik K Kjaergard

  • 1Department of Cardiothoracic Surgery, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Insights

Minimally invasive aortic valve replacement shows promise with zero 30-day mortality in selected patients. However, conversions to full sternotomy increased operative time, and extended procedures should be avoided.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Procedures
  • Aortic Valve Repair

Background:

  • Conventional aortic valve replacement involves a full sternotomy.
  • Minimally invasive approaches aim to reduce surgical trauma and improve recovery.
  • The efficacy and safety of minimally invasive aortic valve replacement (MIAVR) require further investigation.

Purpose of the Study:

  • To evaluate the outcomes of MIAVR compared to conventional aortic valve replacement (AVR).
  • To identify potential risks and benefits associated with MIAVR and extended procedures.

Main Methods:

  • A descriptive prospective study comparing 98 patients undergoing MIAVR with 50 patients undergoing conventional AVR.
  • Data collected included 30-day mortality, intraoperative conversions, operative times, and aortic cross-clamp/perfusion times.

Main Results:

  • Zero 30-day mortality in the MIAVR group.
  • 14% of MIAVR cases required intraoperative conversion to full sternotomy, doubling operative time.
  • Intended full sternotomy group had significantly shorter aortic cross-clamp and perfusion times (P < 0.001).
  • Four late noncardiac deaths occurred in the completed MIAVR group.

Conclusions:

  • MIAVR is an excellent option for selected patients, offering a smaller scar.
  • Randomized trials are needed to confirm MIAVR's advantages over conventional AVR.
  • Extended mini-sternotomies are risky and should be avoided through better preoperative patient selection.